Ribose treatment reduced the infarct size and improved heart function after Myocardial Infarction in rats

Cellular Physiology and Biochemistry

Volumn 24, Issue 3-4, 2009, Pages 211-218

  González, Germán E ^a   Rabald, Steffen ^b   Briest, Wilfried ^b   Gelpi, Ricardo J ^a   Seropian, Ignacio ^a   Zimmer, Heinz Gerd ^b   Deten, Alexander ^c  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c FRAUNHOFER INSTITUTE FOR CELL THERAPY AND IMMUNOLOGY   (Germany)

Author keywords

Cytokine expression; Heart function; Infarct size; Myocardial infarction; Ribose

Indexed keywords

EVANS BLUE; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NEUTROPHIL COLLAGENASE; RIBOSE; SODIUM CHLORIDE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION PROFILING; HEART CATHETERIZATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE RELAXATION; HEART LEFT VENTRICLE WALL; HEART MUSCLE NECROSIS; HEART OUTPUT; HEART PROTECTION; HISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; RIBONUCLEASE PROTECTION ASSAY; SHAM PROCEDURE; SYSTOLIC BLOOD PRESSURE; THERMODILUTION;

ANIMALIA; RATTUS;

EID: 68349135351     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000233247     Document Type: Article

References (39)

1. Reimer KA, Ideker RE: Myocardialischemia and infarction - anatomic and biochemical substrates for ischemic celldeath and ventricular arrhythmias. Hum Pathol 1987;18:462-475.
2. Deten A, Holzl A, Leicht M, Barth W, Zimmer HG: Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol 2001;33:1191-1207.
3. Deten A, Volz HC, Briest W, Zimmer HG: Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 2002;55:329-340.
4. Gourine AV, Hu QS, Sander PR, Kuzmin AI, Hanafy N, Davydova SA, Zaretsky DV, Zhang JY: Interstitial purine metabolites in hearts with Iv remodeling. Am J Physiol Heart Circ Physiol 2004;286:H677-H684.
5. Ridker PM, Antman EM: Pathogenesis and pathology of coronary heart disease syndromes. J Thromb Thrombolysis 1999;8:167-189.
6. Bunger R, Swindall B, Brodie D, Zdunek D, Stiegler H, Walter G: Pyruvate attenuation of hypoxia damage in isolated working guinea-pig heart. J Mol Cell Cardiol 1986;18:423-438.
7. Pasque MK, Wechsler AS: Metabolic intervention to affect myocardial recovery following ischemia. Ann Surg 1984;200:1-12.
8. Bolling SF, Bies LE, Bove EL: Effect of ATP synthesis promoters on postischemic myocardial recovery. J Surg Res 1990;49:205-211.
9. McCully JD, Wakiyama H, Hsieh YJ, Jones M, Levitsky S: Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2004;286:H1923-1935.
10. Baldwin DR, McFalls EO, Jaimes D, Fashingbauer P, Nemzek T, Ward HB: Myocardial glucose metabolism and ATP levels are decreased two days after global ischemia. J Surg Res 1996;63:35-38.
11. Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, Liao RL: Increased myocardial dysfunction after ischemiareperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation 2004;109:898-903.
12. Geisbuhler TP, Schwager TL: Riboseenhanced synthesis of UTP, CTP, and GTP from parent nucleosides in cardiac myocytes. J Mol Cell Cardiol 1998;30:879-887.
13. Kalsi KK, Smolenski RT, Yacoub MH: Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. Mol Cell Biochem 1998;180:193-199.
14. Zimmer HG: Normalization of depressed heart function in rats by ribose. Science 1983;220:81-82.
15. Zimmer HG, Ibel H, Steinkopff G, Korb G: Reduction of the isoproterenolinduced alterations in cardiac adenine nucleotides and morphology by ribose. Science 1980;207:319-321.
16. Zimmer HG, Ibel H, Suchner U, Schad H: Ribose intervention in the cardiac pentose phosphate pathway is not species-specific. Science 1984;223:712-714.
17. Pliml W, von Arnim T, Stablein A, Hofmann H, Zimmer HG, Erdmann E: Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet 1992;340:507-510.
18. Omran H, Illien S, MacCarter D, St Cyr J, Luderitz B: D-ribose improves diastolic function and quality of life in congestive heart failure patients: A prospective feasibility study. Eur J Heart Fail 2003;5:615-619.
19. Zimmer HG: Adenine nucleotide biosynthesis in cardiac muscle: Regulation and intervention. Adv Exp Med Biol 1984;165 Pt B:469-475.
20. Zimmer HG, Martius PA, Marschner G: Myocardial infarction in rats: Effects of metabolic and pharmacologic interventions. Basic Res Cardiol 1989;84:332-343.
21. Zimmer HG, Schneider A: Nucleotide precursors modify the effects of isoproterenol. Studies on heart function and cardiac adenine nucleotide content in intact rats. Circ Res 1991;69:1575-1582.
22. Zimmer HG, Ibel H: Ribose accelerates the repletion of the ATP pool during recovery from reversible ischemia of the rat myocardium. J Mol Cell Cardiol 1984;16:863-866.
23. Wallen WJ, Belanger MP, Wittnich C: Preischemic administration of ribose to delay the onset of irreversible ischemic injury and improve function: Studies in normal and hypertrophied hearts. Can J Physiol Pharmacol 2003;81:40-47.
24. Tan ZT, Wang XW: Verapamil, ribose and adenine enhance resynthesis of postischemic myocardial ATP. Life Sci 1994;55:PL345-PL349.
25. Deten A, Zimmer HG: Heart function and cytokine expression is similar in mice and rats after myocardial infarction but differences occur in TNFalpha expression. Pflugers Arch 2002;445:289-296.
26. Donato M, D'Annunzio V, Berg G, Gonzalez G, Schreier L, Morales C, Wikinski RL, Gelpi RJ: Ischemic postconditioning reduces infarct size by activation of A1 receptors and K+(ATP) channels in both normal and hypercholesterolemic rabbits. J Cardiovasc Pharmacol 2007;49:287-292.
27. Deten A, Volz HC, Briest W, Zimmer HG: Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats. Mol Cell Biochem 2003;242:47-55.
28. Lortet S, Zimmer HG: Functional and metabolic effects of ribose in combination with prazosin, verapamil and metoprolol in rats in vivo. Cardiovasc Res 1989;23:702-708.
29. Zimmer HG: Restitution of myocardial adenine nucleotides: Acceleration by administration of ribose. J Physiol (Paris) 1980;76:769-775.
30. Zimmer HG: Significance of the 5-phosphoribosyl-1-pyrophosphate pool for cardiac purine and pyrimidine nucleotide synthesis: Studies with ribose, adenine, inosine, and orotic acid in rats. Cardiovasc Drugs Ther 1998;12 Suppl 2:179-187.
31. Zimmer HG, Gerlach E: Stimulation of myocardial adenine nucleotide biosynthesis by pentoses and pentitols. Pflugers Arch 1978;376:223-227.
32. Zimmer HG, Ibel H, Suchner U: Betaadrenergic agonists stimulate the oxidative pentose phosphate pathway in the rat heart. Circ Res 1990;67:1525-1534.
33. Zimmer HG, Zierhut W, Marschner G: Combination of ribose with calcium antagonist and beta-blocker treatment in closed-chest rats. J Mol Cell Cardiol 1987;19:635-639.
34. Zimmer HG, Ibel H: Effects of ribose on cardiac metabolism and function in isoproterenol-treated rats. Am J Physiol Heart Circ Physiol 1983;245:H880-886.
35. Zimmer HG: Ribose enhances the isoproterenol-elicited positive inotropic effect in rats in vivo. J Mol Cell Cardiol 1982;14:479-482.
36. Maccarter D, Vijay N, Washam M, Shecterle L, Sierminski H, St Cyr JA: Dribose aids advanced ischemic heart failure patients. Int J Cardiol 2008
37. Reimer KA, Jennings RB, Tatum AH: Pathobiology of acute myocardial ischemia - metabolic, functional and ultrastructural studies. Am J Cardiol 1983;52:A72-A81.
38. Schaper J, Schaper W: Time course of myocardial necrosis. Cardiovasc Drugs Ther 1988;2:17-25.
39. Eckle T, Grenz A, Kohler D, Redel A, Falk M, Rolauffs B, Osswald H, Kehl F, Eltzschig HK: Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 2006;291:H2533-2540.